Healthcare Debt Financing Outlook 2026

The Healthcare Debt Market in 2026

As we enter a new year, it is useful to reflect on the UK healthcare debt market, what we saw in 2025, and what we can expect in the year ahead.

Despite ongoing economic uncertainty and a higher interest rate environment, lender appetite for high-quality healthcare assets remains strong. Competition continues to be particularly pronounced across primary care businesses, often referred to by lenders as the “white coat sectors”.

During 2025, a number of established banking players revisited their credit policies in selected healthcare areas where they are seeking to grow their asset books. This led to small but important shifts across the wider lending market, as other lenders responded by adjusting their own underwriting guidelines.

In such a rapidly evolving environment, it is increasingly difficult for healthcare entrepreneurs to remain fully up to date with changing lender approaches, pricing structures and sector preferences. This is where an experienced corporate debt advisory team can add significant value.

What represented a competitive funding offer in 2025 may already have been overtaken by the terms currently being made available today.

For this reason, a structured and competitive tender process, including your existing relationship bank, remains one of the most effective ways of securing the best terms available in the market.

While pricing is clearly important, other factors such as loan-to-cost or loan-to-valuation, repayment term and amortisation profile can be equally critical. In addition, borrowers must also consider:

  • Early repayment penalties
  • Arrangement Fees
  • Documentation charges
  • Valuation and legal requirements
  • Financial covenants and reporting obligations

The right funding solution is rarely defined by margin alone.

How Lily Head Finance Can Help

At Lily Head Finance, we specialise in advising healthcare business owners, operators and investors on securing tailored debt funding for acquisitions, development and refinancing.

With deep sector expertise and long-standing relationships across the UK’s specialist healthcare banking market, we run competitive funding processes that deliver credit-backed offers aligned to your objectives.

Our role is to reduce the burden on management teams, position proposals effectively, and secure the most appropriate and competitive borrowing terms available.

If you are considering funding options in 2026, please get in touch to discuss how the current lending market applies to your specific sector and future plans.

Facebook
LinkedIn